185 related articles for article (PubMed ID: 28890548)
1. Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases.
Li H; Zuo J; Tang W
Cell Mol Immunol; 2017 Sep; 14(11):887-9. PubMed ID: 28890548
[No Abstract] [Full Text] [Related]
2. Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: therapeutic effects and molecular mechanisms.
Tong X; Chen L; He SJ; Zuo JP
Acta Pharmacol Sin; 2022 Dec; 43(12):3055-3061. PubMed ID: 36050518
[TBL] [Abstract][Full Text] [Related]
3. Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment.
Xiong Y; Huang J
Chin Med; 2021 Aug; 16(1):80. PubMed ID: 34407830
[TBL] [Abstract][Full Text] [Related]
4. Artemisinin derivatives: a patent review (2006 - present).
Njuguna NM; Ongarora DS; Chibale K
Expert Opin Ther Pat; 2012 Oct; 22(10):1179-203. PubMed ID: 22971128
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulation by Artemisinin and Its Derivatives: A New Role for Old Antimalarial Drugs.
Qiu F; Liu J; Mo X; Liu H; Chen Y; Dai Z
Front Immunol; 2021; 12():751772. PubMed ID: 34567013
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of artemisinin and its derivatives in managing kidney diseases.
Jin Q; Liu T; Chen D; Yang L; Mao H; Ma F; Wang Y; Li P; Zhan Y
Front Pharmacol; 2023; 14():1097206. PubMed ID: 36874000
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria.
de Vries PJ; Dien TK
Drugs; 1996 Dec; 52(6):818-36. PubMed ID: 8957153
[TBL] [Abstract][Full Text] [Related]
8. New clinical application prospects of artemisinin and its derivatives: a scoping review.
Huang Y; Yang Y; Liu G; Xu M
Infect Dis Poverty; 2023 Dec; 12(1):115. PubMed ID: 38072951
[TBL] [Abstract][Full Text] [Related]
9. Artemisinins: Promising drug candidates for the treatment of autoimmune diseases.
Gao X; Lin X; Wang Q; Chen J
Med Res Rev; 2024 Mar; 44(2):867-891. PubMed ID: 38054758
[TBL] [Abstract][Full Text] [Related]
10. Immune suppressive properties of artemisinin family drugs.
Hou L; Huang H
Pharmacol Ther; 2016 Oct; 166():123-7. PubMed ID: 27411673
[TBL] [Abstract][Full Text] [Related]
11. The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus.
Jiang YY; Shui JC; Zhang BX; Chin JW; Yue RS
Front Pharmacol; 2020; 11():585487. PubMed ID: 33381036
[TBL] [Abstract][Full Text] [Related]
12. The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases.
Efferth T; Oesch F
Med Res Rev; 2021 Nov; 41(6):3023-3061. PubMed ID: 34288018
[TBL] [Abstract][Full Text] [Related]
13. Potent
Valissery P; Thapa R; Singh J; Gaur D; Bhattacharya J; Singh AP; Dhar SK
RSC Adv; 2020 Sep; 10(59):36201-36211. PubMed ID: 35517081
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin and Derivatives-Based Hybrid Compounds: Promising Therapeutics for the Treatment of Cancer and Malaria.
Peter S; Jama S; Alven S; Aderibigbe BA
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946603
[TBL] [Abstract][Full Text] [Related]
15. [Effects of Artemisinin and Its Derivatives on Oral Microbes].
Zhu CG; Ren B; Cheng L; Zhou XD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Nov; 51(6):760-766. PubMed ID: 33236597
[TBL] [Abstract][Full Text] [Related]
16. [A review of the clinical progress on helminths and their derivative products in autoimmune disease].
Wu X; Gao H; Duan S; Ding W; Yang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Dec; 39(12):1132-1140. PubMed ID: 38140874
[TBL] [Abstract][Full Text] [Related]
17. Artemisinin ameliorates the symptoms of experimental autoimmune myasthenia gravis by regulating the balance of TH1 cells, TH17 cells and Treg cells.
Chen W; Li FF; Li C; Sui JK; Meng QF; Li XL; Li H; Li CH; Li YB
J Biol Regul Homeost Agents; 2018; 32(5):1217-1223. PubMed ID: 30334416
[TBL] [Abstract][Full Text] [Related]
18. Therapeutical Utilization and Repurposing of Artemisinin and Its Derivatives: A Narrative Review.
Guan L; Wang H; Xu X; Fan H
Adv Biol (Weinh); 2023 Aug; 7(8):e2300086. PubMed ID: 37178448
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles Formulations of Artemisinin and Derivatives as Potential Therapeutics for the Treatment of Cancer, Leishmaniasis and Malaria.
Alven S; Aderibigbe BA
Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32784933
[TBL] [Abstract][Full Text] [Related]
20. Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment.
Kumar MS; Yadav TT; Khair RR; Peters GJ; Yergeri MC
Curr Pharm Des; 2019; 25(31):3323-3338. PubMed ID: 31475891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
